Improving warfarin management- identifying risk factors for bleeding and improving monitoring mechanisms

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/519580

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Warfarin is a drug commonly used in the elderly to prevent blood clots. While a very effective drug, it is also a dangerous drug and should be closely monitored. While we know many of the reasons why problems occur, we do not know whether organisation of care, mental health or social issues such as community support influence how well warfarin is managed. These are important questions to answer, so that we can make significant inroads into preventing death and disability from warfarin.

Funded Activity Details

Start Date: 01-01-2008

End Date: 01-01-2012

Funding Scheme: Early Career Fellowships

Funding Amount: $291,309.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Ophthalmology and optometry not elsewhere classified

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

antithrombotic | case-control study | epidemiology | patient management | risk factors

Related Links